X
28Jun

[Audio] Episode 148 -- A Review of the Novartis and Alcon FCPA Enforcement Action

Even during this difficult time of the pandemic, economic uncertainty and social unrest, the Justice Department and the SEC have concluded a major FCPA enforcement action. Novartis and Alcon (which was a Novartis subsidiary at the time of the misconduct) agreed to pay a total of $345 million in criminal and civil penalties. Novartis spun off Alcon in 2019. Under the DOJ settlement, Novartis and Alcon each entered into a deferred prosecution agreement; Novartis agreed to pay a fine of $225...
By: Michael Volkov
Source Url: https://www.jdsupra.com/legalnews/episode-148-a-review-of-the-novartis-40216/

Related

4 Reasons Why Your Organization Isn’t Seeing Internal Hotline Reports

When it comes to effective internal whistleblower hotlines, silence is never a sign of success. It i...

Read More >

DHS commences pilot project to collect DNA from certain travellers

The Department of Homeland Security (DHS) recently announced a pilot project to collect DNA samples ...

Read More >

7th Circuit Holds Retiree Medical Coverage Vested for Life Based on Unambiguous Durational Language in Collective Bargaining Agreement

It is well established that welfare plans are not subject to the vesting requirements of ERISA. Ther...

Read More >

Do Delaware Conversions and Domestications Offer Appraisal Rights? Not under Delaware law.

Business Law Today previously posted this piece discussing key Delaware General Corporate Law differ...

Read More >

Another Challenge for Educational Institutions: Implementing the New Title IX Regulations

As colleges and universities across the country deal with the challenges of remote learning and try ...

Read More >

Employer’s Request To Count Employee’s Prescription Medication Sufficient To Support Invasion Of Privacy Claim

A federal court in Alabama held that an employer’s request to count an employee’s prescription med...

Read More >